Zobrazeno 1 - 10
of 429
pro vyhledávání: '"Lauri, S."'
Publikováno v:
International Family Planning Perspectives, 1998 Sep 01. 24(3), 139-152.
Externí odkaz:
https://www.jstor.org/stable/3038212
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Nigro, G., Adler, S. P., Lasorella, S., Iapadre, G., Maresca, M., Mareri, A., Di Paolantonio, C., Catenaro, M., Tambucci, R., Mattei, I., Carta, G., D'Alfonso, A., Patacchiola, F., Fioroni, M. A., Manganaro, L., Giancotti, A., Pancallo, D., Lauri, S., Liuzzi, G., Di Renzo, G. C., della Torre, B., Lupi, C., Calvario, A., Vimercati, A., Carbonara, S., Gussetti, N., Pisano, P.
Publikováno v:
Clin Infect Dis
Background After primary maternal cytomegalovirus (CMV) infection during pregnancy, infants are at risk for disease. Methods Factors predictive of infant outcome were analyzed in a database of 304 pregnant women with primary infection. These women we
Autor:
Papri Sarkar, Lauri S. Hochberg
Publikováno v:
Obstetrics & Gynecology. 139:85S-85S
Autor:
Bechini A., Bonanni P., Moscadelli A., Lauri S., Tiscione E., Levi M., Prato R., Fortunato F., Martinelli D., Gasparini R., Panatto D., Amicizia D., Coppola R. C., Pellizzari B., Tabacchi G., Costantino C., Casuccio A., Vitale F., Iannazzo S., Boccalini S.
Publikováno v:
Epidemiologia e prevenzione. 43(1)
ESCULAPIO Project, funded by the Centre for Disease Prevention and Control (CCM) of the Italian Ministry of Health, for the program 2013, aims at increasing awareness on vaccine preventable infectious diseases (VPID) and vaccination in different targ
Autor:
Catherine M. Bollard, Christa Krupski, Mary Eapen, Jim A. Connelly, Christine Duncan, Jeffrey R. Andolina, Lauri S Burroughs, Ryan Fleischmann, Carl E. Allen, Michael A. Pulsipher, Rebecca A. Marsh, Michael B. Jordan, K. Scott Baker, Tsz-Kwong Man, Leslie S. Kean, Sung-Yun Pai, Ashley V Geerlinks, Brooks Scull
Publikováno v:
Blood. 138:748-748
Introduction The BMT-CTN 1204 study for Hemophagocytic Syndromes or Selected Primary Immune Deficiencies (NCT01998633) (RICHI) was a single arm study testing safety and efficacy of reduced intensity conditioning (RIC) with alemtuzumab (1mg/kg), fluda
Autor:
Lauri S Burroughs, Ann E. Woolfrey, B. M. Sandmaier, Monica S. Thakar, Rainer Storb, R Pasquini, Carmen Bonfim, Hans-Peter Kiem, Mark C. Walters
Publikováno v:
Bone marrow transplantation
Bone marrow transplantation, vol 52, iss 4
Bone marrow transplantation, vol 52, iss 4
We developed a haploidentical transplantation protocol with post-transplant cyclophosphamide (CY) for in vivo T-cell depletion using a novel adapted-dosing schedule (25 mg/kg on days +3 and +4) for Fanconi Anemia. With median follow-up of 3 years (ra